CoChat

Effect of Ring Fluorination on the Pharmacology of Hallucinogenic Tryptamines

Blair, Joseph B., Kurrasch-Orbaugh, Deborah, Marona-Lewicka, Danuta, Cumbay, Medhane G., Watts, Val J., Barker, Eric L., Nichols, David E. · 2000 · Journal of Medicinal Chemistry

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

A series of fluorinated analogues of the hallucinogenic tryptamines N,N-diethyltryptamine (DET), 4-hydroxy-N,N-dimethyltryptamine (4-OH-DMT, psilocin), and 5-methoxy-DMT was synthesized to investigate possible explanations for the inactivity of 6-fluoro-DET as a hallucinogen and to determine the effects of fluorination on the molecular recognition and activation of these compounds at serotonin receptor subtypes. The target compounds were evaluated using in vivo behavioral assays for hallucinogen-like and 5-HT(1A) agonist activity and in vitro radioligand competition assays for their affinity at 5-HT(2A), 5-HT(2C), and 5-HT(1A) receptor sites. Functional activity at the 5-HT(2A) receptor was determined for all compounds. In addition, for some compounds functional activity was determined at the 5-HT(1A) receptor. Hallucinogen-like activity, evaluated in the two-lever drug discrimination paradigm using LSD-trained rats, was attenuated or abolished for all of the fluorinated analogues. One of the tryptamines, 4-fluoro-5-methoxy-DMT (6), displayed high 5-HT(1A) agonist activity, with potency greater than that of the 5-HT(1A) agonist 8-OH-DPAT. The ED(50) of 6 in the two-lever drug discrimination paradigm using rats trained to discriminate the 5-HT(1A) agonist LY293284 was 0.17 micromol/kg, and the K(i) at [(3)H]8-OH-DPAT-labeled 5-HT(1A) receptors was 0.23 nM. The results indicate that fluorination of hallucinogenic tryptamines generally has little effect on 5-HT(2A/2C) receptor affinity or intrinsic activity. Affinity at the 5-HT(1A) receptor was reduced, however, in all but one example, and all of the compounds tested were full agonists but with reduced functional potency at this serotonin receptor subtype. The one notable exception was 4-fluoro-5-methoxy-DMT (6), which had markedly enhanced 5-HT(1A) receptor affinity and functional potency. Although it is generally considered that hallucinogenic activity results from 5-HT(2A) receptor activation, the present results suggest a possible role for involvement of the 5-HT(1A) receptor with tryptamines.

Overview

Integrity signals

Registry

Crossref · 10.1021/jm000339w

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Research works printed but not linked: 32

  1. LeBars D., 1987, Appl. Radiat. Isot., 38, 1077
  2. Kirk K. L, 1975, J. Org. Chem., 41, 2376
  3. Kirk K. L, 1976, J. Heterocycl. Chem., 13, 1256
  4. Janssen P. A, 1965, Int. Rev. Neurobiol., 8, 263
  5. Smart B. E., 1994, Organofluorine Chemistry: Principles and Commercial Applications (Topics in Applied Chemistry), 88
  6. Park B. K., 1994, Drug Metab. Rev., 26, 643
  7. Howard J. A. K., 1996, Tetrahedron, 52, 12622
  8. Bentov M., 1962, J. Chem. Soc., 2825, 2827
  9. Aldred R., 1994, J. Chem. Soc., Perkin Trans. 1, 1823, 1831
  10. Adams R. E., 1991, Synth. Commun., 12, 681
  11. Speeter M. E., 1954, J. Am. Chem. Soc., 76, 6210
  12. Chen C., 1994, J. Org. Chem., 59, 3741
  13. Hoggett J. G., 1969, Chem. Commun., 605, 606
  14. Desaty D., 1964, Croat. Chem. Acta, 36, 109
  15. Arnt J, 1989, Pharmacol. Toxicol., 64, 172
  16. Nichols D. E., 1997, Handbook of Experimental Pharmacology. Serotoninergic neurons and 5-HT Receptors in the CNS, 585
  17. Marona-Lewicka D., 1997, Soc. Neurosci. Abstr., 23
  18. Kleven M. S., 1997, J. Pharmacol. Exp. Ther., 282, 759
  19. Darmani N. A., 1996, Pharmacol. Biochem. Behav., 55, 10
  20. Darmani N. A, 1998, J. Neural Transm., 105, 643
  21. Strassman R. J, 1996, Behav. Brain Res., 73, 124
  22. Schreiber R., 1995, J. Pharmacol. Exp. Ther., 273, 112
  23. Glennon R. A., 1991, Drug Discrimination: Applications to Drug Abuse Research, 44
  24. Kuipers W., 1994, Drug Des. Discov., 11, 249
  25. Gallaher T. K., 1993, Med. Chem. Res., 3, 66
  26. Johnson M. P., 1994, Mol. Pharmacol., 45, 286
  27. Bergmann E. D., 1959, J. Chem. Soc., 1913, 1914
  28. Niemann C., 1941, J. Am. Chem. Soc., 63, 611
  29. Foreman M. M., 1994, J. Pharmacol. Exp. Ther., 270, 1281
  30. Litchfield J. T., 1949, J. Pharmacol. Exp. Ther., 96, 113
  31. Berg K. A., 1994, Mol. Pharmacol., 46, 484
  32. Watts V. J., 1996, Mol. Pharmacol., 50, 976

Cited by

See all 136

Metadata

Authors
Blair, J. B., Kurrasch-Orbaugh, D., Marona-Lewicka, D., Cumbay, M. G., Watts, V. J., Barker, E. L., & Nichols, D. E.
Affiliations
  • Purdue University West Lafayette (US)
  • Department of Medicinal Chemistry and Molecular Pharmacology, School of Pharmacy and Pharmacal Sciences, Purdue University, West Lafayette, Indiana 47907
Venue
Journal of Medicinal Chemistry
Published
2000-10-19
Volume
43
Issue
24
Pages
4701-4710
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W1972426098
Cited by
131
References
56
Citations by year
2026: 9 · 2025: 9 · 2024: 7 · 2023: 7 · 2022: 7 · 2021: 5 · 2020: 11 · 2019: 4 · 2018: 5 · 2017: 4 · 2016: 7 · 2015: 6 · 2014: 2 · 2013: 5 · 2012: 5
FWCI
2.67
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Institute on Drug Abuse (DA 02189)
Topics
  • Social Sciences › Psychology › Clinical Psychology › Psychedelics and Drug Studies
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Forensic Toxicology and Drug Analysis
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
Keywords
fluorination, 5-HT2A receptor, 5-HT2C receptor, 5-HT1A receptor, drug discrimination, 8-OH-DPAT
MeSH terms
Cyclic AMP, Animals, Binding, Competitive, Discrimination Learning, Drug Evaluation, Preclinical, Fluorine, Colforsin, Hallucinogens, Cricetinae, Humans, Hydrolysis, Phosphatidylinositols, Radioligand Assay, Receptors, Serotonin, Structure-Activity Relationship, Tryptamines, CHO Cells, 3T3 Cells, Serotonin Receptor Agonists, Receptors, Serotonin, 5-HT1, Receptor, Serotonin, 5-HT2A, Receptor, Serotonin, 5-HT2C, Mice, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.